Year: 2020
Type: article
Abstract: Pivoting Research to COVID-19 H igh-impact, translational research projects from the basic, clinical, and/or applied sciences are needed to understand the effects of coronavirus disease 2019 (COVID-19) disease caused by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) virus. In this webinar, the American Neurological Association (ANA) interviewed Dr Shannon Agner, a pediatric neurologist at Washington University in St. Louis, and Dr Chetan Bettegowda, a neurosurgeon at Johns Hopkins University, regarding how they are pivoting their research efforts toward COVID-19. They discussed how they are applying their research expertise in a novel way, first steps and challenges to pivoting, and the role of the neuroscientist in understanding the impact of COVID-19. Leveraging COVID-19-dedicated institutional and financial resources was also discussed. Finally, the disproportionate impact of COVID-19 on individuals of low socioeconomic status and minorities was highlighted as a key research area.
Source: Annals of Neurology
DOI: 10.1002/ana.25784
Institutions: Washington University in St. Louis, Johns Hopkins University
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3024879523